Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.

Current treatment options in oncology - 1 Feb 2007

Lin Amy, Rugo Hope S

Abstract excerpt

OPINION STATEMENT: Treatment of early stage breast cancer requires a multimodality approach in order to eradicate residual cancer and prevent recurrent disease. Targeting the pathways that promote or sustain cancer cell growth and invasion is critical to the effective treatment of breast and othe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Interactions

Share to Drug Resistance, Neoplasm

Share to Lymphatic Metastasis

Share to Medical Oncology

Share to Trastuzumab

Source

Identifiers

PMID: 17660958
DOI: 10.1007/s11864-007-0008-2

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17660958-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.PMID 17660958Read ↗

Advances in EGFR/HER2-directed clinical research on breast cancer.Semantic proximity Read ↗

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.Semantic proximity Read ↗

Facts and controversies in the use of trastuzumab in the adjuvant setting.Semantic proximity Read ↗

Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testing.Semantic proximity Read ↗

Targeted and cytotoxic inhibitors used in the treatment of breast cancerSemantic proximity Read ↗

The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.Semantic proximity Read ↗

Optimizing chemotherapy regimens for patients with early-stage breast cancer.Semantic proximity Read ↗

Update on the Treatment of Early-Stage Triple-Negative Breast CancerSemantic proximity Read ↗

The Evolving Landscape of HER2 Targeting in Breast Cancer.Semantic proximity Read ↗

Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer: the DAISY trialSemantic proximity Read ↗

Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast CancerSemantic proximity Read ↗

Prevalence and Effects of Late Cardiotoxicity induced by Anthracyclines and/or Anti- HER2 Antibodies in Patients with Breast Cancer: a real world studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.